nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—adrenal gland cancer	0.715	0.767	CbGaD
Lidocaine—ABCB1—adrenal gland cancer	0.217	0.233	CbGaD
Lidocaine—CYP1A2—urine—adrenal gland cancer	0.00115	0.0949	CbGeAlD
Lidocaine—CYP2C9—urine—adrenal gland cancer	0.00109	0.09	CbGeAlD
Lidocaine—CYP3A4—urine—adrenal gland cancer	0.00083	0.0687	CbGeAlD
Lidocaine—CYP2D6—urine—adrenal gland cancer	0.000816	0.0676	CbGeAlD
Lidocaine—EGFR—adrenal gland—adrenal gland cancer	0.000731	0.0605	CbGeAlD
Lidocaine—SCN9A—pituitary gland—adrenal gland cancer	0.000674	0.0557	CbGeAlD
Lidocaine—SCN9A—adrenal gland—adrenal gland cancer	0.000602	0.0498	CbGeAlD
Lidocaine—SCN4A—pituitary gland—adrenal gland cancer	0.000601	0.0497	CbGeAlD
Lidocaine—SCN4A—adrenal gland—adrenal gland cancer	0.000537	0.0444	CbGeAlD
Lidocaine—SCN2A—pituitary gland—adrenal gland cancer	0.000532	0.044	CbGeAlD
Lidocaine—SCN10A—pituitary gland—adrenal gland cancer	0.000513	0.0424	CbGeAlD
Lidocaine—SCN5A—cardiac atrium—adrenal gland cancer	0.000477	0.0395	CbGeAlD
Lidocaine—SCN3A—pituitary gland—adrenal gland cancer	0.000467	0.0387	CbGeAlD
Lidocaine—SCN3A—adrenal gland—adrenal gland cancer	0.000418	0.0346	CbGeAlD
Lidocaine—SLC22A5—adrenal cortex—adrenal gland cancer	0.000335	0.0277	CbGeAlD
Lidocaine—CYP2B6—adrenal cortex—adrenal gland cancer	0.000291	0.0241	CbGeAlD
Lidocaine—SLC22A5—cardiac atrium—adrenal gland cancer	0.000277	0.0229	CbGeAlD
Lidocaine—SLC22A5—pituitary gland—adrenal gland cancer	0.000271	0.0224	CbGeAlD
Lidocaine—CYP2C8—pituitary gland—adrenal gland cancer	0.000262	0.0217	CbGeAlD
Lidocaine—SLC22A5—adrenal gland—adrenal gland cancer	0.000242	0.02	CbGeAlD
Lidocaine—CYP2B6—gonad—adrenal gland cancer	0.000241	0.02	CbGeAlD
Lidocaine—CYP2B6—adrenal gland—adrenal gland cancer	0.00021	0.0174	CbGeAlD
Lidocaine—ABCB1—adrenal cortex—adrenal gland cancer	0.000156	0.0129	CbGeAlD
Lidocaine—ABCB1—gonad—adrenal gland cancer	0.000129	0.0107	CbGeAlD
Lidocaine—ABCB1—pituitary gland—adrenal gland cancer	0.000126	0.0104	CbGeAlD
Lidocaine—ABCB1—adrenal gland—adrenal gland cancer	0.000112	0.00929	CbGeAlD
Lidocaine—EGFR—Signaling by ERBB2—BAD—adrenal gland cancer	0.000102	0.00183	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—BAD—adrenal gland cancer	0.000102	0.00182	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000101	0.00182	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—BAD—adrenal gland cancer	0.0001	0.0018	CbGpPWpGaD
Lidocaine—EGFR—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.0001	0.00179	CbGpPWpGaD
Lidocaine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	9.97e-05	0.00179	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	9.89e-05	0.00177	CbGpPWpGaD
Lidocaine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	9.88e-05	0.00177	CbGpPWpGaD
Lidocaine—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.84e-05	0.00176	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MED12—adrenal gland cancer	9.75e-05	0.00175	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—PTGS2—adrenal gland cancer	9.73e-05	0.00174	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	9.72e-05	0.00174	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—BAD—adrenal gland cancer	9.57e-05	0.00171	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—BAD—adrenal gland cancer	9.57e-05	0.00171	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—BAD—adrenal gland cancer	9.57e-05	0.00171	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—BAD—adrenal gland cancer	9.48e-05	0.0017	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—BAD—adrenal gland cancer	9.4e-05	0.00168	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—BAD—adrenal gland cancer	9.36e-05	0.00168	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—BRAF—adrenal gland cancer	9.35e-05	0.00168	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—BRAF—adrenal gland cancer	9.35e-05	0.00168	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—CDC42—adrenal gland cancer	9.21e-05	0.00165	CbGpPWpGaD
Lidocaine—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	9.12e-05	0.00163	CbGpPWpGaD
Lidocaine—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—adrenal gland cancer	9.11e-05	0.00163	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—BRAF—adrenal gland cancer	9.08e-05	0.00163	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—BAD—adrenal gland cancer	9.04e-05	0.00162	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	9e-05	0.00161	CbGpPWpGaD
Lidocaine—EGFR—Immune System—SH3KBP1—adrenal gland cancer	8.87e-05	0.00159	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	8.87e-05	0.00159	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—BAD—adrenal gland cancer	8.85e-05	0.00159	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	8.72e-05	0.00156	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—BRAF—adrenal gland cancer	8.71e-05	0.00156	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	8.47e-05	0.00152	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—CDC42—adrenal gland cancer	8.45e-05	0.00151	CbGpPWpGaD
Lidocaine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	8.44e-05	0.00151	CbGpPWpGaD
Lidocaine—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	8.35e-05	0.0015	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	8.33e-05	0.00149	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—BRAF—adrenal gland cancer	8.23e-05	0.00147	CbGpPWpGaD
Lidocaine—EGFR—Disease—SH3KBP1—adrenal gland cancer	8.19e-05	0.00147	CbGpPWpGaD
Lidocaine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	8.08e-05	0.00145	CbGpPWpGaD
Lidocaine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	8.01e-05	0.00144	CbGpPWpGaD
Lidocaine—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	7.79e-05	0.0014	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways in Glioblastoma—TP53—adrenal gland cancer	7.75e-05	0.00139	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	7.71e-05	0.00138	CbGpPWpGaD
Lidocaine—EGFR—Disease—ZNRF3—adrenal gland cancer	7.7e-05	0.00138	CbGpPWpGaD
Lidocaine—CYP2A6—Biological oxidations—POMC—adrenal gland cancer	7.65e-05	0.00137	CbGpPWpGaD
Lidocaine—SCN9A—Axon guidance—EGFR—adrenal gland cancer	7.54e-05	0.00135	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—SDHB—adrenal gland cancer	7.47e-05	0.00134	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—RRM1—adrenal gland cancer	7.24e-05	0.0013	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—SDHD—adrenal gland cancer	7.24e-05	0.0013	CbGpPWpGaD
Lidocaine—SCN3A—Axon guidance—EGFR—adrenal gland cancer	7.21e-05	0.00129	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	7.19e-05	0.00129	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	7.15e-05	0.00128	CbGpPWpGaD
Lidocaine—SLC22A5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	7.05e-05	0.00126	CbGpPWpGaD
Lidocaine—SCN2A—Axon guidance—EGFR—adrenal gland cancer	6.93e-05	0.00124	CbGpPWpGaD
Lidocaine—SCN4A—Axon guidance—EGFR—adrenal gland cancer	6.93e-05	0.00124	CbGpPWpGaD
Lidocaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.85e-05	0.00123	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—SDHB—adrenal gland cancer	6.84e-05	0.00123	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—CTNNB1—adrenal gland cancer	6.79e-05	0.00122	CbGpPWpGaD
Lidocaine—SCN10A—Axon guidance—EGFR—adrenal gland cancer	6.68e-05	0.0012	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	6.62e-05	0.00119	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—BAD—adrenal gland cancer	6.52e-05	0.00117	CbGpPWpGaD
Lidocaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	6.52e-05	0.00117	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—CTNNB1—adrenal gland cancer	6.49e-05	0.00116	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PRKACA—adrenal gland cancer	6.28e-05	0.00113	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—GNRH1—adrenal gland cancer	6.26e-05	0.00112	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—CTNNB1—adrenal gland cancer	6.24e-05	0.00112	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—CTNNB1—adrenal gland cancer	6.24e-05	0.00112	CbGpPWpGaD
Lidocaine—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	6.18e-05	0.00111	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GNRHR—adrenal gland cancer	6.17e-05	0.00111	CbGpPWpGaD
Lidocaine—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	6.04e-05	0.00108	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—CDC42—adrenal gland cancer	6.03e-05	0.00108	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PRKACA—adrenal gland cancer	6.03e-05	0.00108	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—CTNNB1—adrenal gland cancer	6.02e-05	0.00108	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—CTNNB1—adrenal gland cancer	5.95e-05	0.00107	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—BRAF—adrenal gland cancer	5.93e-05	0.00106	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	5.92e-05	0.00106	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	5.91e-05	0.00106	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	5.91e-05	0.00106	CbGpPWpGaD
Lidocaine—EGFR—Spinal Cord Injury—TP53—adrenal gland cancer	5.79e-05	0.00104	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SH3KBP1—adrenal gland cancer	5.74e-05	0.00103	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—TSHR—adrenal gland cancer	5.58e-05	0.000999	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—SDHB—adrenal gland cancer	5.52e-05	0.000989	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—SDHB—adrenal gland cancer	5.4e-05	0.000967	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—MED12—adrenal gland cancer	5.4e-05	0.000967	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ZNRF3—adrenal gland cancer	5.39e-05	0.000966	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—EGFR—adrenal gland cancer	5.38e-05	0.000964	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CDC42—adrenal gland cancer	5.33e-05	0.000954	CbGpPWpGaD
Lidocaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.28e-05	0.000947	CbGpPWpGaD
Lidocaine—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	5.23e-05	0.000937	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—EGFR—adrenal gland cancer	5.15e-05	0.000922	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDC42—adrenal gland cancer	5.12e-05	0.000917	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—TP53—adrenal gland cancer	5.05e-05	0.000905	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.04e-05	0.000904	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—EGFR—adrenal gland cancer	4.94e-05	0.000886	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—EGFR—adrenal gland cancer	4.94e-05	0.000886	CbGpPWpGaD
Lidocaine—EGFR—Disease—SPRY2—adrenal gland cancer	4.83e-05	0.000865	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—SDHD—adrenal gland cancer	4.81e-05	0.000862	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—RRM1—adrenal gland cancer	4.81e-05	0.000862	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—EGFR—adrenal gland cancer	4.77e-05	0.000854	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	4.75e-05	0.000852	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—EGFR—adrenal gland cancer	4.7e-05	0.000841	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—SDHB—adrenal gland cancer	4.68e-05	0.000838	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	4.54e-05	0.000814	CbGpPWpGaD
Lidocaine—EGFR—Disease—MEN1—adrenal gland cancer	4.42e-05	0.000793	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—SDHD—adrenal gland cancer	4.41e-05	0.00079	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—RRM1—adrenal gland cancer	4.41e-05	0.00079	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—adrenal gland cancer	4.37e-05	0.000782	CbGpPWpGaD
Lidocaine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	4.29e-05	0.000769	CbGpPWpGaD
Lidocaine—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	4.26e-05	0.000762	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—CTNNB1—adrenal gland cancer	4.23e-05	0.000758	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	4.1e-05	0.000735	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—SDHB—adrenal gland cancer	4.07e-05	0.00073	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PRKACA—adrenal gland cancer	4e-05	0.000717	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.94e-05	0.000706	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PRKACA—adrenal gland cancer	3.94e-05	0.000705	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	3.84e-05	0.000688	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SDHB—adrenal gland cancer	3.8e-05	0.000682	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—BAD—adrenal gland cancer	3.72e-05	0.000666	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GNRH1—adrenal gland cancer	3.7e-05	0.000662	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	3.68e-05	0.000659	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PRKACA—adrenal gland cancer	3.66e-05	0.000655	CbGpPWpGaD
Lidocaine—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	3.64e-05	0.000652	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—MED12—adrenal gland cancer	3.59e-05	0.000643	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—BAD—adrenal gland cancer	3.57e-05	0.00064	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—RRM1—adrenal gland cancer	3.56e-05	0.000638	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—SDHD—adrenal gland cancer	3.56e-05	0.000638	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3.51e-05	0.000628	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—RRM1—adrenal gland cancer	3.48e-05	0.000623	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—SDHD—adrenal gland cancer	3.48e-05	0.000623	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—CDC42—adrenal gland cancer	3.4e-05	0.000608	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—SPRY2—adrenal gland cancer	3.38e-05	0.000606	CbGpPWpGaD
Lidocaine—EGFR—Disease—PRKACA—adrenal gland cancer	3.38e-05	0.000605	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EGFR—adrenal gland cancer	3.35e-05	0.0006	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	3.34e-05	0.000599	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TSHR—adrenal gland cancer	3.3e-05	0.00059	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—MED12—adrenal gland cancer	3.29e-05	0.000589	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SDHB—adrenal gland cancer	3.25e-05	0.000583	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—GNAS—adrenal gland cancer	3.24e-05	0.000581	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GNAS—adrenal gland cancer	3.19e-05	0.000572	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ABCB1—adrenal gland cancer	3.13e-05	0.000561	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDC42—adrenal gland cancer	3.1e-05	0.000556	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MEN1—adrenal gland cancer	3.1e-05	0.000555	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	3.05e-05	0.000546	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—RRM1—adrenal gland cancer	3.01e-05	0.00054	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—SDHD—adrenal gland cancer	3.01e-05	0.00054	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.99e-05	0.000537	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	2.99e-05	0.000536	CbGpPWpGaD
Lidocaine—EGFR—Disease—CDC42—adrenal gland cancer	2.86e-05	0.000513	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.81e-05	0.000503	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—CTNNB1—adrenal gland cancer	2.77e-05	0.000496	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—MED12—adrenal gland cancer	2.65e-05	0.000475	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—RRM1—adrenal gland cancer	2.62e-05	0.00047	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—SDHD—adrenal gland cancer	2.62e-05	0.00047	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	2.62e-05	0.000469	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—MED12—adrenal gland cancer	2.59e-05	0.000465	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.56e-05	0.000458	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.51e-05	0.00045	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	2.47e-05	0.000443	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	2.47e-05	0.000443	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	2.47e-05	0.000443	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SDHD—adrenal gland cancer	2.45e-05	0.000439	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—RRM1—adrenal gland cancer	2.45e-05	0.000439	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CTNNB1—adrenal gland cancer	2.45e-05	0.000438	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PRKACA—adrenal gland cancer	2.4e-05	0.00043	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	2.37e-05	0.000424	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PRKACA—adrenal gland cancer	2.36e-05	0.000424	CbGpPWpGaD
Lidocaine—EGFR—Disease—TERT—adrenal gland cancer	2.3e-05	0.000412	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—MED12—adrenal gland cancer	2.25e-05	0.000402	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—POMC—adrenal gland cancer	2.18e-05	0.000391	CbGpPWpGaD
Lidocaine—EGFR—Immune System—BAD—adrenal gland cancer	2.17e-05	0.000388	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—POMC—adrenal gland cancer	2.15e-05	0.000385	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GNAS—adrenal gland cancer	2.12e-05	0.00038	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—RRM1—adrenal gland cancer	2.1e-05	0.000375	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SDHD—adrenal gland cancer	2.1e-05	0.000375	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	2.08e-05	0.000373	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.01e-05	0.00036	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CDC42—adrenal gland cancer	2.01e-05	0.000359	CbGpPWpGaD
Lidocaine—EGFR—Disease—BAD—adrenal gland cancer	2e-05	0.000358	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.99e-05	0.000356	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—MED12—adrenal gland cancer	1.96e-05	0.000351	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GNAS—adrenal gland cancer	1.94e-05	0.000348	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	1.94e-05	0.000347	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IGF2—adrenal gland cancer	1.93e-05	0.000346	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GNAS—adrenal gland cancer	1.92e-05	0.000343	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ABCB1—adrenal gland cancer	1.91e-05	0.000342	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	1.89e-05	0.000339	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IGF1R—adrenal gland cancer	1.87e-05	0.000335	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—MED12—adrenal gland cancer	1.84e-05	0.00033	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—MED12—adrenal gland cancer	1.83e-05	0.000328	CbGpPWpGaD
Lidocaine—EGFR—Disease—BRAF—adrenal gland cancer	1.82e-05	0.000326	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTGS2—adrenal gland cancer	1.71e-05	0.000307	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	1.64e-05	0.000294	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.63e-05	0.000293	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.62e-05	0.00029	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.62e-05	0.00029	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TERT—adrenal gland cancer	1.61e-05	0.000288	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.6e-05	0.000287	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GNAS—adrenal gland cancer	1.57e-05	0.000281	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—MED12—adrenal gland cancer	1.56e-05	0.00028	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	1.54e-05	0.000276	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GNAS—adrenal gland cancer	1.53e-05	0.000275	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	1.5e-05	0.00027	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTGS2—adrenal gland cancer	1.47e-05	0.000263	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—POMC—adrenal gland cancer	1.43e-05	0.000256	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.43e-05	0.000256	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CTNNB1—adrenal gland cancer	1.42e-05	0.000255	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—BAD—adrenal gland cancer	1.4e-05	0.000251	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.4e-05	0.00025	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	1.35e-05	0.000241	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	1.33e-05	0.000239	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GNAS—adrenal gland cancer	1.33e-05	0.000238	CbGpPWpGaD
Lidocaine—EGFR—Disease—CTNNB1—adrenal gland cancer	1.32e-05	0.000236	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—POMC—adrenal gland cancer	1.31e-05	0.000235	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.3e-05	0.000234	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	1.3e-05	0.000234	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—POMC—adrenal gland cancer	1.29e-05	0.000231	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—BRAF—adrenal gland cancer	1.27e-05	0.000228	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.21e-05	0.000216	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.16e-05	0.000207	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	1.14e-05	0.000204	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	1.14e-05	0.000204	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.11e-05	0.0002	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.09e-05	0.000195	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	1.08e-05	0.000194	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.07e-05	0.000192	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	1.06e-05	0.00019	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—POMC—adrenal gland cancer	1.06e-05	0.000189	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—adrenal gland cancer	1.04e-05	0.000187	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—POMC—adrenal gland cancer	1.03e-05	0.000185	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	9.24e-06	0.000165	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CTNNB1—adrenal gland cancer	9.21e-06	0.000165	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	9.06e-06	0.000162	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—POMC—adrenal gland cancer	8.94e-06	0.00016	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	8.8e-06	0.000158	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	8.42e-06	0.000151	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	8.23e-06	0.000148	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—POMC—adrenal gland cancer	7.79e-06	0.00014	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—POMC—adrenal gland cancer	7.34e-06	0.000132	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—POMC—adrenal gland cancer	7.28e-06	0.00013	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	7.13e-06	0.000128	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	7.13e-06	0.000128	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	7e-06	0.000125	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—POMC—adrenal gland cancer	6.22e-06	0.000111	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	6.21e-06	0.000111	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—adrenal gland cancer	6.13e-06	0.00011	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	5.86e-06	0.000105	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	5.8e-06	0.000104	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	4.96e-06	8.89e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—POMC—adrenal gland cancer	4.8e-06	8.6e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.83e-06	6.86e-05	CbGpPWpGaD
